CClinicalTrials.gg
CompletedNCT02883686Updated May 6, 2020

Randomized Controlled Trial of the Alma Peer Mentoring Program for Pregnant Women Experiencing Depression

An interventional study of Alma in Depression and Depression, Postpartum, sponsored by University of Colorado, Boulder. Completed at 2 sites in United States. Open to female participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-05-06.

Sponsored by University of Colorado, Boulder · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
27
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

Women have double the odds of getting depressed as men and commonly experience depression during the childbearing and early parenting years. Many new and expectant mothers who experience depression never receive help. Alma is a new program, collaboratively developed by a team of researchers, clinicians, and mothers who have personal experience with depression, to support women experiencing depression during pregnancy and the postpartum period. In the Alma program, mothers who themselves have experienced and recovered from depression during the perinatal period, are trained to provide peer mentoring to depressed new and expectant mothers. Peer mentors are trained by professionals who are experts in using skills to recover from depression. These skills are informed by an evidence-based framework called Behavioral Activation (BA). Peer mentors do not provide psychotherapy and are not licensed mental health providers.

Read the detailed description

Women have double the odds of getting depressed as men and commonly experience depression during the childbearing and early parenting years. Many new and expectant mothers who experience depression never receive help.

Alma is a new program, collaboratively developed by a team of researchers, clinicians, and mothers who have personal experience with depression, to support women experiencing depression during pregnancy and the postpartum period. We call this program Alma because the meaning of the word, in English and Spanish, captures what we hope moms will feel when they connect with this program. In English, the meaning comes from the Latin word for "nourishing" and "kind," and in Spanish, the meaning is "soul." Through the unique synergy of science and community, the Alma program provides the tools and support needed to nourish moms in supporting their own well-being.

In the Alma program, mothers who themselves have experienced and recovered from depression during the perinatal period, are trained to provide peer mentoring to depressed new and expectant mothers. Peer mentors are trained to provide 6-10 mentoring meetings with each of the new and expectant mothers with whom they are paired. The peer mentors are trained by professionals who are experts in using skills to recover from depression. These skills are informed by an evidence-based framework called Behavioral Activation (BA). Peer Mentors are trained to support and encourage self-monitoring, scheduling activities, solving problems, and bridging to informal and formal professional support. Peer mentors draw on their training and own lived experience to provide hope and reduce the social isolation and stigma associated with perinatal depression. Among the evidence-based approaches to help people recover from depression, Alma uses BA as a lens because many studies have demonstrated that these skills are effective in recovering from depression. It has been provided in a self-guided format and by lay counselors and licensed mental health providers. Peer mentors do not provide psychotherapy and are not licensed mental health providers.

02

Conditions studied

  • Depression
  • Depression, Postpartum

Keywords

  • Perinatal Depression
  • Postpartum Depression
  • Pregnancy
  • Peer-delivered
  • Task-sharing
03

In context

Depression, Postpartum

528 studies on the registry are indexed under Depression, Postpartum; 124 are open to participants now.

This study's enrollment of 27 is below the median of 105 across 425 interventional studies indexed under Depression, Postpartum.

Browse Depression, Postpartum studies →

Lead sponsor

University of Colorado, Boulder is the lead sponsor of 86 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Currently enrolled member of Kaiser Permanente of Colorado (KPCO)
  • Current PHQ-9 score greater than or equal to 10
  • Current Columbia-Suicide Severity Rating Scale (C-SSRS) score less than 3
  • Currently pregnant

Exclusion criteria

Exclusion Criteria:

  • Lifetime diagnosis of bipolar disorder or psychotic symptoms
  • Dementia or cognitive impairment disorder recorded in the medical record
  • Current substance abuse behavior
  • At immediate risk of self-harm
  • Unable to speak and read English
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
27 participants (actual)

Study arms

  • Experimental
    Alma Mentoring plus usual care

    Alma peer-mentoring

    Behavioral: Alma

  • No intervention
    Enhanced Usual Care

    Usual care for depression within the Kaiser Permanente of Colorado healthcare system plus study monitoring of depression symptoms and feedback.

Interventions

  • BehavioralAlma

    Alma peer-mentoring

06

What researchers measure

Primary outcomes

  1. Change in Patient Health Questionnaire (PHQ-9) score

    Self-report measure of depression symptoms.

    Time frame: Every 2 weeks for the first 12 weeks of the study, then monthly until 3-months postpartum

Secondary outcomes

  1. Change in Generalized Anxiety Disorder Questionnaire (GAD-7) score

    Self-report measure of generalized anxiety symptoms.

    Time frame: Every 2 weeks for the first 12 weeks of the study, then monthly until 3-months postpartum

  2. Change in Perceived Stress Scale (PSS-10) score

    Self-report measure of stress.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  3. Change in WHO Disability Assessment Schedule (WHODAS 2.0) score

    Self-report measure of health, disability, and functioning.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  4. Parenting Stress Index-Short Form (PSI-4/SF)

    Self-reported stress in the parent-child system.

    Time frame: 3-months postpartum

  5. Change in Behavioral Activation for Depression Scale (BADS) score

    Self-report questionnaire that assesses activation in daily life: Activation, Avoidance/Rumination, Work/School Impairment, and Social Impairment.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  6. Change in Reward-Probability Index (RPI) score

    Self-report questionnaire that assess proxy dimensions of response-contingent positive reinforcement: reward probability and environmental suppressors inhibiting access to reinforcement.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  7. Change in Environmental Reward Observation Scale (EROS) score

    Self-report questionnaire that assess the experience of environmental reward over the past several weeks.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  8. Change in Attitudes Toward Motherhood (AToM) score

    Self-report questionnaire that assess women's attitudes about motherhood, including beliefs related to others' judgments, beliefs about maternal responsibility, and maternal role idealization.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  9. Working Alliance Inventory - Short Form (Intervention group only)

    Self-report questionnaire that assess participant's working alliance with their peer mentor.

    Time frame: 12-weeks post-randomization

  10. Change in Self- Compassion Scale (SCS) score

    Self-report measure of self-compassion.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  11. Mother Inventory of Reward Experiences (MIRE)

    Self-report questionnaire assessing reward responsivity in parenting.

    Time frame: 3-months postpartum

  12. Change in Social Support Questionnaire - Short Form (SSQ-SF) score

    Self-report questionnaire assessing social support available to a participant and their perception of the quality of that social support.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  13. Client Satisfaction Questionnaire (CSQ-8)

    Self-report measure of general satisfaction with the Alma program. Participants randomized to treatment as usual will receive a CSQ-8 to measure general satisfaction with Kaiser Permanente of Colorado mental health services.

    Time frame: 12-weeks post-randomization

  14. Change in Effort-Expenditure for Rewards Task (EEfRT) performance

    Computerized behavior task administered remotely that assesses effort-based decision-making.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  15. Change in Experience Sampling Survey response

    Momentary mood and activity assessed by self-report triggered by text-message prompt to complete a survey.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  16. Change in Go/No-Go Task (GNAT) performance

    Computerized behavior task administered remotely that assesses implicit associations pairing the self with both stigma and belonging.

    Time frame: Baseline, 12-weeks post-randomization, 3-months postpartum

  17. Exit Interview

    An Exit Interview will be administered to solicit participant feedback about the Alma program and recommendations for improvement, including questions about overall program and specific Alma components, including telephone- or videoconference- based delivery, length and number of sessions, spacing between sessions, peer characteristics, and ease of access to peers.

    Time frame: 3-months postpartum

07

Study locations

2 sites
  • Kaiser Permanente of Colorado
    Aurora, Colorado 80014, United States
  • University of Colorado Boulder
    Boulder, Colorado 80309, United States
08

References and documents

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 6, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02883686
Lead sponsor
University of Colorado, Boulder
Collaborators
Kaiser Permanente, Emory University
Responsible party
Sona Dimidjian (Professor, University of Colorado, Boulder) — Principal investigator
First posted
Aug 30, 2016
Start date
Feb 6, 2019
Primary completion
Apr 28, 2020
Completion
Apr 28, 2020
Last update
May 6, 2020

Study contacts

Sona Dimidjian, PhD
principal investigator · University of Colorado, Boulder
Arne Beck, PhD
principal investigator · Kaiser Permanente

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion